Update: Follicum Press Release from April 23. 50% recruitment for these Phase IIa clinical trials has been reached.
Sometimes, news items concerning major developments in the hair loss cure world suddenly bombard us like an incessant rainfall. This is certainly the case so far this month. Always a great feeling to get this type of drenching, but very time consuming! Earlier today, a commentator named “Camaro” notified us that Sweden based Follicum’s latest investor presentation from the BioStock conference was already available on youtube.
Although I just wrote a post earlier today, I decided to add this short one too since the below linked video presentation by Follicum is worth a watch. I have covered this company and its FOL-005 hair loss product many times on this blog in the past. My February post that discussed Follicum is worth a reread. Currently, FOL-005 is in Phase IIA clinical trials (in early March they announced that the first patient in these trials was just treated).
Once you click on the link, the below video will start right after company CEO Jan Alenfall arrives on stage. Some very interesting slides in the presentation, including one with the implication that, at best, this product will work slightly better than Minoxidil. Such an upfront declaration makes me trust the company more. The biggest news is that they are seeing a very high 75 percent successful response rate in initial results (Edit: Might have been referring to earlier trial results). They are testing out powder, cream and gel based topical formulations of FOL-005 in order to compound the best possible final topical product.
I am on Follicum’s mailing list and will add a link to the slides on here if they happen to send one.